A cation exchange chromatography process for purifying a GLP-1 peptide from a mixture comprising said peptide and related impurities, comprising the step of: separating said GLP-1 peptide and said related impurities of said mixture by elution in a solution consisting essentially of an organic modifier, water, optionally a salt component, and optionally a buffer, with a linear or step gradient or isocratically in salt component and/or with a linear or step pH-gradient or at a constant pH-value, wherein the pH-gradient or pH-value should be in the range where said peptide has a positive local or overall net charge different from the local or overall positive net charge of said related impurities so as to remove said related impurities

One potential mechanism is the Nrf2-ARE pathway, which induces a phase 2 detoxification response that promotes disruption of Nrf2-Keap protein interactions, translocation of Nrf2 to the nucleus, and regulation of target gene expression through the ARE, enhancing cellular defense against oxidative damage (Hu et al., 2004
Not intended for human consumption, clinical diagnosis, or therapeutic application
Inhibiting PFKFB3 attenuates TGF-1 + IL-1-stimulated NLRP3 inflammasome activation and fibroblast activation The effects of PFKFB3-driven glycolysis on NLRP3 inflammasome activation in fibroblasts under the stress of TGF-1 + IL-1 were investigated by using 3PO, a selective PFKFB3 inhibitor